A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma

Background Gliomas represent the most common and aggressive brain malignancy. Interferon-gamma (IFNG) is a potent inducer of immune response, developing IFNG-related gene signature may promote the diagnosis and treatment of this disease. Methods Bulk tumor and single-cell mRNA-seq datasets of glioma ranging from WHO grade II to IV with corresponding demographics were included. Multiple bioinformatics and machine learning algorithms were performed to develop an IFNG-related prognostic signature and evaluate immune checkpoint blockade (ICB) therapy response. Results IFNGR1 and IFNGR2 were used as concise IFNG-related gene signature based on which the IFNGR score well-characterized the IFNG response in the glioma microenvironment. Increased IFNGR score was associated with clinicopathological parameters relating to tumor malignancy and prevailing molecular pathological markers. Notably, K-M and Cox regression analysis found that the IFNGR score was an effective prognostic biomarker, and was associated with tumor relapse for a subset of patients. Notably, IFNGR1 and IFNGR2 were preferentially expressed by the Mono/Macro cells in the glioma microenvironment and were significantly correlated with M2 macrophage. Thus, the IFNGR score-high group had increased expression of immune checkpoints and had the potential to predict ICB responsiveness. Conclusion In conclusion, we have developed a concise IFNG-related gene signature of clinical significance, which may improve the current diagnosis and treatment of glioma.

Abstract licence: CC BY

1. 10.

   Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets · 2007

2. 16.

   limma powers differential expression analyses for RNA-sequencing and microarray studies · 2015

3. 18.

   GSVA: gene set variation analysis for microarray and RNA-Seq data · 2013

4. 22.

   Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation · 2014

5. 27.

   Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas · 2017

6. 30.

   IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma · 2017

7. 33.

   Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion · 2018

8. 36.

   The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy · 2018

9. 38.

   Metascape provides a biologist-oriented resource for the analysis of systems-level datasets · 2019

10. 48.

    Integrated analysis of multimodal single-cell data · 2021

41 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.